Solute Carrier Family 39 (Zinc Transporter), Member 13 (SLC39A13) (Middle Region) Peptide
-
- Target See all SLC39A13 products
- SLC39A13 (Solute Carrier Family 39 (Zinc Transporter), Member 13 (SLC39A13))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- WVIAGILTFL ALEKMFLDSK EEGTSQAPNK DPTAAAAALN GGHCLAQPAA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SLC39A13 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SLC39A13 (Solute Carrier Family 39 (Zinc Transporter), Member 13 (SLC39A13))
- Background
-
This gene encodes a member of the LIV-1 subfamily of the ZIP transporter family. The encoded transmembrane protein functions as a zinc transporter. Mutations in this gene have been associated with the spondylocheiro dysplastic form of Ehlers-Danlos syndrome. Alternate transcript variants have been found for this gene.
Alias Symbols: LZT-Hs9
Protein Size: 364 - Gene ID
- 91252
- NCBI Accession
- NM_001128225, NP_001121697
-